Management_of_low-grade_cervical_dysplasia_during_pregnancy._Fifty-five_pregnant_patients_referred_to_my_colposcopy_service_from_1985_to_1990_for_biopsy-proven_mild_dysplasia_were_entered_into_a_program_of_serial_evaluations,_including_Pap_test,_colposcopy,_and_directed_biopsy_if_indicated._The_evaluations_were_done_every_12_weeks_during_pregnancy_and_at_6_weeks_postpartum_to_rule_out_new_or_occult_invasive_cervical_cancer._By_the_time_the_postpartum_biopsy_was_done,_no_such_cancer_had_been_detected._All_55_patients_had_mild_dysplasia_or_less._I_conclude_that_pregnant_patients_with_biopsy-proven_mild_cervical_dysplasia_who_have_had_adequate_expert_colposcopy_and_results_of_Pap_test_consistent_with_biopsy_require_only_one_antepartum_colposcopy_prior_to_postpartum_reevaluation_and_treatment._Multiple_interval_cytologic_and_colposcopic_studies_with_or_without_biopsy_are_unnecessary._The_likelihood_of_invasive_cervical_cancer_developing_in_these_patients_during_pregnancy_is_negligible.